Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
出版年份 2012 全文链接
标题
Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes
作者
关键词
-
出版物
Current Cardiology Reports
Volume 14, Issue 6, Pages 721-731
出版商
Springer Nature
发表日期
2012-09-02
DOI
10.1007/s11886-012-0309-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Efficacy of Omega-3 Fatty Acid Supplements (Eicosapentaenoic Acid and Docosahexaenoic Acid) in the Secondary Prevention of Cardiovascular Disease
- (2012) Seung-Kwon Myung ARCHIVES OF INTERNAL MEDICINE
- Statins are diabetogenic – Myth or reality?
- (2012) Naveed Sattar et al. ATHEROSCLEROSIS SUPPLEMENTS
- Healthy Lifestyle Through Young Adulthood and the Presence of Low Cardiovascular Disease Risk Profile in Middle Age
- (2012) Kiang Liu et al. CIRCULATION
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
- (2012) Samia Mora et al. CIRCULATION
- Executive Summary: Heart Disease and Stroke Statistics—2012 Update
- (2012) et al. CIRCULATION
- Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood
- (2012) Tomi T. Laitinen et al. CIRCULATION
- Triglycerides
- (2012) Anthony S. Wierzbicki et al. CURRENT OPINION IN CARDIOLOGY
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Endothelial dysfunction in type 2 diabetes
- (2012) A. Natali et al. DIABETOLOGIA
- Inhibition of hepatic sulfatase-2 In Vivo: A novel strategy to correct diabetic dyslipidemia
- (2012) H. Carlijne Hassing et al. HEPATOLOGY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of Statin Effects in Women Versus Men
- (2012) William J. Kostis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The biology and therapeutic targeting of the proprotein convertases
- (2012) Nabil G. Seidah et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging role of HDL in glucose metabolism
- (2012) Brian G. Drew et al. Nature Reviews Endocrinology
- Do Persons with Diabetes Benefit from Combination Statin and Fibrate Therapy?
- (2012) Paul D. Rosenblit Current Cardiology Reports
- Role of ω3 Longchain Polyunsaturated Fatty Acids in Reducing Cardio- Metabolic Risk Factors
- (2012) Mahinda Y. Abeywardena et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Hyperlipidemia
- (2011) Michel Farnier American Journal of Cardiovascular Drugs
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism
- (2011) Changting Xiao et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
- (2011) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A 1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
- (2011) Philip J. Barter et al. CIRCULATION
- Rosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial
- (2011) Z. Awan et al. CLINICAL CHEMISTRY
- Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
- (2011) F. Karpe et al. DIABETES
- Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials
- (2011) L. A. Leiter et al. DIABETES OBESITY & METABOLISM
- Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?
- (2011) D. Kromhout et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipid control in patients with diabetes mellitus
- (2011) D. John Betteridge Nature Reviews Cardiology
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia
- (2010) Ann C Skulas-Ray et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of High-Density Lipoproteins on Pancreatic β-Cell Insulin Secretion
- (2010) Michelle A. Fryirs et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
- (2010) Donald M. Lloyd-Jones et al. CIRCULATION
- A practical approach to the metabolic syndrome: review of current concepts and management
- (2010) Rajesh Tota-Maharaj et al. CURRENT OPINION IN CARDIOLOGY
- Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes
- (2010) M.-R. Taskinen et al. DIABETOLOGIA
- Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies
- (2010) Dick C Chan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
- (2010) Eric Bruckert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
- (2010) Elisa Fabbrini et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
- (2010) Min Jun et al. LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Combination Lipid Therapy in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk
- (2009) M.T. Cooney et al. ATHEROSCLEROSIS
- Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
- (2009) Paul M Ridker et al.
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Wirksamkeit und Sicherheit von Etofibrat bei Patienten mit nicht proliferativer diabetischer Retinopathie
- (2009) K.-H. Emmerich et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives
- (2008) William S. Harris et al. ATHEROSCLEROSIS
- Cost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes: Results and projections from the Steno-2 study
- (2008) P. Gaede et al. DIABETES CARE
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Effect of Statins Alone Versus Statins Plus Ezetimibe on Carotid Atherosclerosis in Type 2 Diabetes
- (2008) Jerome L. Fleg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now